Carl Johan Bertil Sundberg
Director/Board Member bij SANA AB
Vermogen: 10 612 $ op 31-03-2024
Profiel
Carl Johan Bertil Sundberg is the founder of Karolinska Investment Fund KB.
He currently holds the position of Chairman-Learning & Informatics Department at Karolinska Institutet.
He is also an Independent Director at Saniona AB, a Director at Arne Ljungqvist Anti-Doping Foundation AB, a Director at Medkay Konsulting AB, a Director at Saniona A, a Member of the International Olympic Committee, a Member of the Royal Swedish Academy of Engineering Sciences, and a Partner at Medkay Konsulting HB.
In the past, Dr. Sundberg has held positions such as Director at Cellectricon AB, Director at Feelgood Svenska AB, Director at Global Genomics AB, Director at NsGene A, Investment Director at KI Management AB from 1999 to 2009, Director at AngioGenetics AB, Director at Alfta Rehab Center Holding AB, Non-Executive Director at Cobra Biologics Ltd., Independent Director at Karolinska Development AB from 2014 to 2017, Director at Cobra Biologics Holding AB, Director at Ki Management Partners AB, and Vice President at EuroScience.
He obtained his doctorate degree from Karolinska Institutet.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
SANIONA AB
0.05% | 31-12-2022 | 58 856 ( 0.05% ) | 10 612 $ | 31-03-2024 |
Actieve functies van Carl Johan Bertil Sundberg
| Bedrijven | Functie | Begin |
|---|---|---|
| SANA AB | Director/Board Member | 01-01-2015 |
Saniona A/S
 Saniona A/S Miscellaneous Commercial ServicesCommercial Services Part of Saniona AB, Saniona A/S is a Danish company dedicated to improving the lives of rare disease patients worldwide through scientific innovation. The private company focuses on Prader-Willi Syndrome, a rare genetic disorder characterized by insatiable appetite, abnormal growth and body composition, low muscle tone, and social/emotional/cognitive deficits. Saniona is a leader in the discovery of highly specific ion channel modulators, which is a validated approach to treating diseases such as diabetes, hypertension, and epilepsy. The company's robust ion channel drug discovery engine has led to the development of San711, a first-in-class positive allosteric modulator of GABAA ?3 receptors, and San903, a potential first-in-class inhibitor of the calcium-activated potassium ion channel, KCA3.1, both of which are in development for rare neuropathic, inflammatory, and fibrotic disorders. | Director/Board Member | 01-01-2016 |
International Olympic Committee
 International Olympic Committee Movies/EntertainmentConsumer Services International Olympic Committee Organizes Olympic games. The company was founded by Pierre de Coubertin on June 23 1894 and is headquartered in Lausanne, Switzerland. | Corporate Officer/Principal | - |
| Medkay Konsulting HB | Corporate Officer/Principal | - |
| Medkay Konsulting AB | Director/Board Member | - |
| Arne Ljungqvist Anti-Doping Foundation AB | Director/Board Member | - |
Royal Swedish Academy of Engineering Sciences
 Royal Swedish Academy of Engineering Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Swedish Academy of Engineering Sciences (IVA) is an organization that brings together around 1,300 academy members and 250 companies to bridge the gap between academia, business, and politics. The non-profit company is based in Stockholm, Sweden. The Swedish company's aim is to work towards people's ability to contribute positively to society. The organization runs an internship program called Tekniksprånget, which gives young people in Sweden the opportunity to test the engineering profession through a four-month paid internship. The program has been running since 2012 and aims to inspire more people to choose a higher technical education. The CEO of the company is Björn O. Nilsson. | Corporate Officer/Principal | - |
| Karolinska Institutet | Corporate Officer/Principal | - |
Eerdere bekende functies van Carl Johan Bertil Sundberg
| Bedrijven | Functie | Einde |
|---|---|---|
| KAROLINSKA DEVELOPMENT AB | Director/Board Member | 24-05-2017 |
| ░░ ░░░░░░░░░░ ░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░ ░░░░░░░░░░ ░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░░░░░ ░░░░░░░░░░ ░░░░ ░░ | ░░░░░░░ | - |
Opleiding van Carl Johan Bertil Sundberg
| Karolinska Institutet | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| KAROLINSKA DEVELOPMENT AB | Finance |
| SANA AB | Health Technology |
| Bedrijven in privébezit | 18 |
|---|---|
Cellectricon AB
 Cellectricon AB Miscellaneous Commercial ServicesCommercial Services Cellectricon AB provides cell-based screening services to accelerate drug discovery. The firm develops and validates exciting central nervous system and peripheral pain assays using primary cells, accelerating the path from assay validation to compound screening. Its system is equipped with an imaging-based microplate reader to simultaneously record transient fluorescence and luminescence signals, providing real-time monitoring and readouts of cell culture response. The company was founded by Jan Owe Owesson Orwar, Daniel T. Chiu and Stig Anders Jakob Lindberg in 1999 and is headquartered in Molndal, Sweden. | Commercial Services |
Feelgood Svenska AB
 Feelgood Svenska AB Medical/Nursing ServicesHealth Services Feelgood Svenska AB engages in the provision of healthcare services. Its operations include occupational health, training, primary care, physical education, and physiotherapy. The firm serves businesses, organizations, and private individuals. The company was founded in 1995 and is headquartered in Stockholm, Sweden. | Health Services |
Global Genomics AB
 Global Genomics AB Miscellaneous Commercial ServicesCommercial Services Global Genomics AB used to discovers disease genes, drug targets and disease-associated biomarkers. It was also developing and out-licenses proprietary tools in functional genomics that provide insight into healthy, diseased or drug-treated cells. The company was founded by Patrik Ernfors & Sten Linnarsson in September, 2000 and was located in Stockholm, Sweden. | Commercial Services |
NsGene A/S
 NsGene A/S Pharmaceuticals: MajorHealth Technology NsGene A/S identifies neurotrophic proteins with therapeutic effects in the nervous system. It is a biotechnology company that focuses primarily on neurodegenerative disorders. The firm provides technologies that target protein therapeutics across the blood-brain-barrier and directly to diseased nerve cells. It develops therapeutic products for multiple indications with high medical needs including Alzheimer’s disease, Parkinson's disease, deafness, neuropathic pain, epilepsy, cortico-basal degeneration, and Huntington’s disease. The company was founded by Lars Ulrik Wahlberg and Teit Eliot Johansen in 1999 and is headquartered in Ballerup, Denmark. | Health Technology |
International Olympic Committee
International Olympic Committee Movies/EntertainmentConsumer Services International Olympic Committee Organizes Olympic games. The company was founded by Pierre de Coubertin on June 23 1894 and is headquartered in Lausanne, Switzerland. | Consumer Services |
Karolinska Investment Fund KB
 Karolinska Investment Fund KB Investment ManagersFinance Karolinska Investment Fund KB is a healthcare-focused fund based in Stockholm. Targeted portfolio companies are pharmaceutical, biotechnology and medical technology companies located in Sweden. | Finance |
Royal Swedish Academy of Engineering Sciences
Royal Swedish Academy of Engineering Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Swedish Academy of Engineering Sciences (IVA) is an organization that brings together around 1,300 academy members and 250 companies to bridge the gap between academia, business, and politics. The non-profit company is based in Stockholm, Sweden. The Swedish company's aim is to work towards people's ability to contribute positively to society. The organization runs an internship program called Tekniksprånget, which gives young people in Sweden the opportunity to test the engineering profession through a four-month paid internship. The program has been running since 2012 and aims to inspire more people to choose a higher technical education. The CEO of the company is Björn O. Nilsson. | Commercial Services |
AngioGenetics AB
 AngioGenetics AB Pharmaceuticals: GenericHealth Technology AngioGenetics AB develops, markets, and distributes generic drugs. It develops angiogenesis modulating drugs for the treatment of cancer, ischemic heart disease, and eye diseases. The company was founded in June 2001 and is headquartered in Göteborg, Sweden. | Health Technology |
| Alfta Rehab Center Holding AB | |
Cobra Biologics Ltd.
 Cobra Biologics Ltd. Pharmaceuticals: MajorHealth Technology Cobra Biologics Ltd. engages in development of DNA-based technologies, services and products. It is a international contract development and manufacturing organization (CDMO) providing biologics and pharmaceuticals for pre-clinical, clinical and commercial supply. The company was founded in 1992 and is headquartered in Keele, the United Kingdom. | Health Technology |
Cobra Biologics Holding AB
 Cobra Biologics Holding AB Pharmaceuticals: MajorHealth Technology Cobra Biologics Holding AB manufactures biologics and pharmaceuticals for pre-clinical, clinical, and commercial products. Its services include gene therapies and vaccines, products for testing, process development and scale up of vaccine products, production of sterile drug products, and process development and production, automation, and traceability of programs. The company was founded in 2011 and is headquartered in S?dert?lje, Sweden. | Health Technology |
EuroScience
 EuroScience Miscellaneous Commercial ServicesCommercial Services EuroScience engages in the advancement of science. The non-profit company is based in Strasbourg, France. | Commercial Services |
| Arne Ljungqvist Anti-Doping Foundation AB | |
| Medkay Konsulting AB | |
| Medkay Konsulting HB | |
Saniona A/S
Saniona A/S Miscellaneous Commercial ServicesCommercial Services Part of Saniona AB, Saniona A/S is a Danish company dedicated to improving the lives of rare disease patients worldwide through scientific innovation. The private company focuses on Prader-Willi Syndrome, a rare genetic disorder characterized by insatiable appetite, abnormal growth and body composition, low muscle tone, and social/emotional/cognitive deficits. Saniona is a leader in the discovery of highly specific ion channel modulators, which is a validated approach to treating diseases such as diabetes, hypertension, and epilepsy. The company's robust ion channel drug discovery engine has led to the development of San711, a first-in-class positive allosteric modulator of GABAA ?3 receptors, and San903, a potential first-in-class inhibitor of the calcium-activated potassium ion channel, KCA3.1, both of which are in development for rare neuropathic, inflammatory, and fibrotic disorders. | Commercial Services |
| Ki Management Partners AB | |
KI Management AB
 KI Management AB Investment ManagersFinance KI Management AB (KIM) is a venture capital investment firm located in Stockholm, on the campus of the Karolinska Institute. They are the investment advisor and manager of the Karolinska Investment Fund KB (KIF). The fund was established in 1999 by the Karolinska Institute and Alecta, a Nordic pension plan. KIM has a partnership agreement with Karolinska Innovations AB, a technology transfer entity of the Karolinska Institute. The Karolinska Institute, founded in 1810, has a medical focus and is responsible for selecting the winner of the Nobel Prize in Physiology or Medicine. | Finance |
